Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, NICE Ltd. insiders sold a net $50.0K of stock across 1 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Foreign private issuer: most of its insiders are exempt from SEC Form 4, but some still file it; those filings are listed below, and the record may be incomplete.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
No other insider sold within 30 days.
146 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: VP, Corporate Finance Dayan Udi Yehuda sold about $50.0K of NICE on Aug 7, 2026, the largest insider sale at the company on our record; 146 funds added in the latest 13F quarter.
1 transaction on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
NICE planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
UDI YEHUDA DAYAN
Filed 2026-08-07
$50.0K
NICE mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Vulcan Value Partners Fund
$7.1M position · as of 2026-07-31
3.1%
Artisan International Small-Mid Fund
$60.9M position · as of 2026-06-30
2.4%
Amplify BlueStar Israel Technology ETF
$2.6M position · as of 2026-06-30
2.2%
Brown Advisory International Value Select ETF
$2.1M position · as of 2026-06-30
1.9%
Parnassus Value Select ETF
$428.4K position · as of 2026-06-30
1.7%
Royce International Premier Fund
$1.1M position · as of 2026-06-30
1.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $50.0K sold by insiders over 180 days, 146 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $50.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Free cash flow, TTM NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Single quarter
Debt to equity
0.00x
long-term 2024-12-31 plus current 2025-12-31; equity 2025-12-31
Debt to equity NICE
FY Dec 2025
0.00x
FY Dec 2024
0.13x
FY Dec 2023
0.20x
FY Dec 2022
0.22x
FY Dec 2021
0.29x
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
needs four quarters of operating cash flow
Cash flow to debt NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$7.0B
market value at close 2026-10-26 on 2025-12-31 shares, plus long-term 2024-12-31 plus current 2025-12-31, minus cash 2025-12-31
Enterprise value NICE
FY Dec 2025
$6.5B
FY Dec 2024
$10.7B
FY Dec 2023
$12.7B
FY Dec 2022
$12.4B
FY Dec 2021
$19.7B
none filed
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
fewer than four consecutive quarters of operating cash flow
FCF yield NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing NICE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
none filed
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
NICE ranks highest on financial health (99th percentile) and institutional and government (69th), and lowest on insider conviction (38th), among Software & IT peers.
Financial health
100
Inputs
Debt to equity0.00x · 100 pct, sector of 288
Cash flow to debtneeds four quarters of operating cash flow
Growth
57
Inputs
Revenue growth, YoY+7.7% · 46 pct, sector of 480
Backlog growth, YoY+19.6% · 68 pct, sector of 182
Insider conviction
38
Inputs
Net Form 4 buying (codes P and S), 180d-$50K · 76 pct, sector of 284
Insider buyers, 180d0 · 0 pct, sector of 290
Institutional and government
69
Inputs
Funds adding, latest quarter146 · 63 pct, sector of 415
Congress net buyers, 365d1 · 76 pct, sector of 72
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
69
Inputs
Short interest, % of shares outstanding (no float on file)+2.1% · 69 pct, sector of 528
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NICE filings, in plain words
Are Nice insiders buying or selling NICE?
In the 180 days to 2026-10-28, Nice insiders were net sellers, a net $50.0K across purchases and sales reported on Form 4, by 1 seller.
Have members of Congress traded NICE?
Yes. In the year to 2026-10-28, 1 House member disclosed buying NICE and 0 House members disclosed selling it; the latest on record is a purchase by Josh Gottheimer dated 2026-07-20.
Are there planned insider sales of NICE?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-28, covering $50.0K of stock; the latest, by UDI YEHUDA DAYAN, was filed 2026-08-07.
Read the full summary
In the 180 days to 2026-10-28, Nice insiders were net sellers of NICE, a net $50.0K across purchases and sales reported on Form 4 by 1 seller. In the year to 2026-10-28, 1 member of Congress disclosed buying NICE and 0 members disclosed selling it; the latest on record is a purchase by Josh Gottheimer dated 2026-07-20. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-28, covering $50.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.